A phase I trial of Proton stereotactic body radiation therapy for liver metastases

BACKGROUND: A phase I trial to determine the maximum tolerated dose (MTD) of Proton stereotactic body radiation therapy (SBRT) for liver metastases in anticipation of a subsequent phase II study. METHODS: An institutional IRB approved phase I clinical trial was conducted. Eligible patients had 1–3 l...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Gastrointest Oncol
Hoofdauteurs: Kang, Joseph I., Sufficool, Daniel C., Hsueh, Chung-Tsen, Wroe, Andrew J., Patyal, Baldev, Reeves, Mark E., Slater, Jerry D., Yang, Gary Y.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AME Publishing Company 2019
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6351312/
https://ncbi.nlm.nih.gov/pubmed/30788166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.08.17
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items